TCL Archive AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier September 26, 1986
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention. March 2, 2007
